Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas

Autor: Axel Van Der Gucht, John O. Prior, Jean-Philippe Brouland, Marie Nicod-Lalonde, Vincent Dunet, Jocelyne Bloch, Karl-Josef Langen, Niklaus Schaefer, Antoine Verger, Paul Blanc-Durand
Přispěvatelé: Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Imagerie Adaptative Diagnostique et Interventionnelle (IADI), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Médecine Nucléaire [Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Universitätsklinikum RWTH Aachen - University Hospital Aachen [Aachen, Germany] (UKA), RWTH Aachen University, This work was supported by a grant from the Lionel Perrier Foundation (Montreux, Switzerland), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Lausanne University Hospital, Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), BIRKER, Juliette, Rheinisch-Westfälische Technische Hochschule Aachen University (RWTH)
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
[INFO.INFO-IM] Computer Science [cs]/Medical Imaging
lcsh:Medicine
Kaplan-Meier Estimate
computer.software_genre
Diagnostic Radiology
030218 nuclear medicine & medical imaging
0302 clinical medicine
Voxel
Positron Emission Tomography Computed Tomography
Image Processing
Computer-Assisted

Medicine and Health Sciences
Cluster Analysis
Blastomas
lcsh:Science
Neurological Tumors
Tomography
Cultured Tumor Cells
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
Multidisciplinary
medicine.diagnostic_test
Radiology and Imaging
Astrocytoma
Glioma
Middle Aged
Prognosis
Magnetic Resonance Imaging
Isocitrate Dehydrogenase
3. Good health
Adult
Biomarkers
Tumor

Female
Follow-Up Studies
Glioma/diagnostic imaging
Glioma/genetics
Glioma/mortality
Glioma/pathology
Humans
Isocitrate Dehydrogenase/genetics
Mutation
Neoplasm Grading
Neoplasm Staging
Positron-Emission Tomography
Tyrosine/analogs & derivatives
CZT
Oncology
Neurology
Positron emission tomography
030220 oncology & carcinogenesis
SPECT
Biological Cultures
ddc:500
Research Article
Imaging Techniques
Oligodendroglioma
Brain tumor
Neuroimaging
[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine
Research and Analysis Methods
[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine
03 medical and health sciences
Diagnostic Medicine
Cancer Detection and Diagnosis
medicine
[INFO.INFO-IM]Computer Science [cs]/Medical Imaging
bone scintigraphy
vertebral fracture
Astrocytoma Cells
business.industry
lcsh:R
Cancers and Neoplasms
Biology and Life Sciences
Magnetic resonance imaging
Cell Cultures
medicine.disease
Tumor progression
standardized uptake value
Tyrosine
lcsh:Q
Nuclear medicine
business
computer
Positron Emission Tomography
Glioblastoma Multiforme
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Neuroscience
Zdroj: PLOS ONE 13(6), e0199379 (2018). doi:10.1371/journal.pone.0199379
PLoS ONE
PLoS ONE, Public Library of Science, 2018, 13 (6), pp.e0199379. ⟨10.1371/journal.pone.0199379⟩
Europe PubMed Central
PLoS ONE, Vol 13, Iss 6, p e0199379 (2018)
PLoS ONE, Public Library of Science, 2018, 13, ⟨10.1371/journal.pone.0199379⟩
PloS one, vol. 13, no. 6, pp. e0199379
PLoS one 13(6), e0199379-(2018). doi:10.1371/journal.pone.0199379
PLoS ONE, 2018, 13 (6), pp.e0199379. ⟨10.1371/journal.pone.0199379⟩
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0199379
Popis: International audience; IntroductionAim was to develop a full automatic clustering approach of the time-activity curves (TAC) from dynamic 18F-FET PET and evaluate its association with IDH1 mutation status and survival in patients with gliomas.MethodsThirty-seven patients (mean age: 45±13 y) with newly diagnosed gliomas and dynamic 18F-FET PET before any histopathologic investigation or treatment were retrospectively included. Each dynamic 18F-FET PET was realigned to the first image and spatially normalized in the Montreal Neurological Institute template. A tumor mask was semi-automatically generated from Z-score maps. Each brain tumor voxel was clustered in one of the 3 following centroids using dynamic time warping and k-means clustering (centroid #1: slowly increasing slope; centroid #2: rapidly increasing followed by slowly decreasing slope; and centroid #3: rapidly increasing followed by rapidly decreasing slope). The percentage of each dynamic 18F-FET TAC within tumors and other conventional 18F-FET PET parameters (maximum and mean tumor-to-brain ratios [TBRmax and TBRmean], time-to-peak [TTP] and slope) was compared between wild-type and IDH1 mutant tumors. Their prognostic value was assessed in terms of progression free-survival (PFS) and overall survival (OS) by Kaplan-Meier estimates.ResultsTwenty patients were IDH1 wild-type and 17 IDH1 mutant. Higher percentage of centroid #1 and centroid #3 within tumors were positively (P = 0.016) and negatively (P = 0.01) correlated with IDH1 mutated status. Also, TBRmax, TBRmean, TTP, and slope discriminated significantly between tumors with and without IDH1 mutation (P range 0.01 to 0.04). Progression occurred in 22 patients (59%) at a median of 13.1 months (7.6–37.6 months) and 13 patients (35%) died from tumor progression. Patients with a percentage of centroid #1 > 90% had a longer survival compared with those with a percentage of centroid #1 < 90% (P = 0.003 for PFS and P = 0.028 for OS). This remained significant after stratification on IDH1 mutation status (P = 0.029 for PFS and P = 0.034 for OS). Compared to other conventional 18F-FET PET parameters, TTP and slope were associated with PFS and OS (P range 0.009 to 0.04).ConclusionsBased on dynamic 18F-FET PET acquisition, we developed a full automatic clustering approach of TAC which appears to be a valuable noninvasive diagnostic and prognostic marker in patients with gliomas.
Databáze: OpenAIRE